The Primary
Care Companionfor CNS Disorders

Primary Care

Editorial June 15, 2005

Editorial: Mental Health Disorders and Their Descriptive Criteria in Primary Care: Clarifying or Confounding?

Donald E. Nease, Jr.; James E. Aikens; Thomas L. Schwenk

Prim Care Companion J Clin Psychiatry 2005;7(3):89-90

Article Abstract

Editorial: Mental Health Disorders and Their Descriptive Criteria in Primary Care: Clarifying or Confounding?

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 26 • 2024 • Number 6

Read the Current Issue

Narrative Review

Dextromethorphan-Quinidine for Agitation in Dementia

Original Research

Psychiatric Comorbidities in Adolescents With Polycystic Ovary Syndrome

Original Research

Intervention to Enhance Mental Health Competency

Original Research

Evolution of Treatment Modalities for PTSD

Rounds in the General Hospital

Etiology, Prevention, and Management of TD

Rounds in the General Hospital

Comorbid Bipolar Disorder and PTSD

View current Issue